BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PRA International, Inc. (PRAI) Opens New Office in Poland


12/9/2010 7:35:05 AM

RALEIGH, N.C., Dec. 9, 2010 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, is pleased to announce that our Warsaw, Poland-based Early Development Services (EDS) and Product Registration teams have recently relocated into a new, larger office to accommodate their continuing growth.

Previously, PRA's Polish EDS and Product Registration units operated in separate offices. According to Dr. Ludger Langer, PRA's Vice President of Clinical Operations in Europe, Asia-Pacific, and Africa, having both groups under one roof will create beneficial synergies, enhance internal and external communications, and enable our teams to serve clients from one of the city's primary business districts.

Like other PRA EDS locations in Central and Eastern Europe, the Warsaw EDS team uses our innovative unit-on-demand business model that brings a Phase I center to patients. This model establishes a Phase I study environment in central medical facilities that specialize in treating target patient populations.

"The combined office in a central city location will enable us to serve our on-demand units better and further improve our combined capabilities in this important market," said Dr. Christian Reh, PRA's Vice President of Early Development for Central & Eastern Europe.

PRA's Product Registration group provides project management, clinical operations and other services for Phase II-III studies. It is instrumental in helping our clients conduct complex, global, multi-center trials across a range of therapeutic areas.

About PRA International

PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 3000 clinical trials through its 38 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES